Subsequently, the stable transfected efficacy of FOXR2 in ECs after overexpression or silencing is shown in Fig. 6b TEER value and HRP flux in the glioma-conditioned normal BBB model were determined. The gene discussed is FOXR2; the disease is central nervous system cancer.